134 related articles for article (PubMed ID: 11137571)
21. Cells behaving badly: a theoretical model for the Fas/FasL system in tumour immunology.
Webb SD; Sherratt JA; Fish RG
Math Biosci; 2002; 179(2):113-29. PubMed ID: 12208611
[TBL] [Abstract][Full Text] [Related]
22. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover.
French LE; Hahne M; Viard I; Radlgruber G; Zanone R; Becker K; Müller C; Tschopp J
J Cell Biol; 1996 Apr; 133(2):335-43. PubMed ID: 8609166
[TBL] [Abstract][Full Text] [Related]
23. Irradiation-induced up-regulation of Fas in esophageal squamous cell carcinoma is not accompanied by Fas ligand-mediated apoptosis.
Rigberg DA; Centeno J; Kim FS; Ke B; Swenson K; Maggard M; McFadden DW
J Surg Oncol; 1999 Jun; 71(2):91-6. PubMed ID: 10389864
[TBL] [Abstract][Full Text] [Related]
24. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma.
Choi C; Park JY; Lee J; Lim JH; Shin EC; Ahn YS; Kim CH; Kim SJ; Kim JD; Choi IS; Choi IH
J Immunol; 1999 Feb; 162(4):1889-95. PubMed ID: 9973455
[TBL] [Abstract][Full Text] [Related]
25. [Expression of FAS and FASL genes in brain and effect of flunarizine on these expressions in rats after global ischemia-reperfusion].
Liu YJ; Xue CS; Zhou QX
Yao Xue Xue Bao; 2000 Nov; 35(11):810-3. PubMed ID: 11218854
[TBL] [Abstract][Full Text] [Related]
26. Proteasome inhibitors induce Fas-mediated apoptosis by c-Myc accumulation and subsequent induction of FasL message in human glioma cells.
Tani E; Kitagawa H; Ikemoto H; Matsumoto T
FEBS Lett; 2001 Aug; 504(1-2):53-8. PubMed ID: 11522296
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Fas/FasL mRNA expression and TNF-alpha release in concanavalin A-induced liver injury in mice by bicyclol.
Li M; Liu GT
World J Gastroenterol; 2004 Jun; 10(12):1775-9. PubMed ID: 15188504
[TBL] [Abstract][Full Text] [Related]
28. [Effects of dexamethasone on apoptosis and expression of Fas/FasL system in lung tissues of ALI rats].
Song Y; Mao B; Qian G
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jan; 23(1):23-6. PubMed ID: 11778176
[TBL] [Abstract][Full Text] [Related]
29. Exposure to exogenous DNA can modify the sensitivity of the Fas apoptotic pathway.
de Carvalho Bittencourt M; Saas P; Fresnay S; Yerly-Motta V; Ferrand C; Perruche S; Duperrier A; Hervé P; Tiberghien P; Chalmers DE
J Gene Med; 2002; 4(1):14-24. PubMed ID: 11828383
[TBL] [Abstract][Full Text] [Related]
30. Soluble Fas-ligand (sFasL) in human astrocytoma cyst fluid is cytotoxic to T-cells: another potential means of immune evasion.
Frankel B; Longo SL; Canute GW
J Neurooncol; 2000 May; 48(1):21-6. PubMed ID: 11026693
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis induced in T cells by human neuroblastoma cells: role of Fas ligand.
Shurin GV; Gerein V; Lotze MT; Barksdale EM
Nat Immun; 1998; 16(5-6):263-74. PubMed ID: 11061594
[TBL] [Abstract][Full Text] [Related]
32. Fas/FasL mediated apoptosis of thyrocytes in Graves' disease.
Sera N; Kawakami A; Nakashima T; Nakamura H; Imaizumi M; Koji T; Abe Y; Usa T; Tominaga T; Ejima E; Ashizawa K; Yokoyama N; Ishikawa N; Ito K; Eguchi K
Clin Exp Immunol; 2001 May; 124(2):197-207. PubMed ID: 11422195
[TBL] [Abstract][Full Text] [Related]
33. Fas mRNA expression and calcium influx change in H2O2-induced apoptotic hepatocytes in vitro.
Lu QP; Tian L
World J Gastroenterol; 2005 Jan; 11(4):534-7. PubMed ID: 15641141
[TBL] [Abstract][Full Text] [Related]
34. Induction of apoptosis in glioma cells by recombinant human Fas ligand.
Kawaguchi S; Mineta T; Ichinose M; Masuoka J; Shiraishi T; Tabuchi K
Neurosurgery; 2000 Feb; 46(2):431-8; discussion 438-9. PubMed ID: 10690733
[TBL] [Abstract][Full Text] [Related]
35. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
36. Fas/Fas ligand (FasL)-deregulated apoptosis and IL-6 insensitivity in highly malignant myeloma cells.
Frassanito MA; Silvestris F; Silvestris N; Cafforio P; Camarda G; Iodice G; Dammacco F
Clin Exp Immunol; 1998 Nov; 114(2):179-88. PubMed ID: 9822274
[TBL] [Abstract][Full Text] [Related]
37. Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia.
Ortiz-Arduan A; Danoff TM; Kalluri R; González-Cuadrado S; Karp SL; Elkon K; Egido J; Neilson EG
Am J Physiol; 1996 Dec; 271(6 Pt 2):F1193-201. PubMed ID: 8997393
[TBL] [Abstract][Full Text] [Related]
38. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
[TBL] [Abstract][Full Text] [Related]
39. Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system.
Kayisli UA; Selam B; Guzeloglu-Kayisli O; Demir R; Arici A
J Immunol; 2003 Sep; 171(5):2305-13. PubMed ID: 12928375
[TBL] [Abstract][Full Text] [Related]
40. Suppression of Fas expression and down-regulation of Fas ligand in highly aggressive human thyroid carcinoma.
Basolo F; Fiore L; Baldanzi A; Giannini R; Dell'Omodarme M; Fontanini G; Pacini F; Danesi R; Miccoli P; Toniolo A
Lab Invest; 2000 Sep; 80(9):1413-9. PubMed ID: 11005209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]